Nvelop Therapeutics
nChroma
Cambridge, United States · Founded 2022 · $100.0M raised
- Headquarters
- Cambridge
- Employees
- 51–200
- Founded
- 2022
- Business Model
- B2B
- Website
- nveloptx.com
- Total Funding
- $100.0M
- Last Round
- $100.0M SeedApr 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.
About
Nvelop Therapeutics (now nChroma Bio) was founded in 2022 to develop programmable, non-viral in vivo delivery systems for next-generation genetic medicines. The company combines disease-first therapeutic design with targeted delivery technologies to engineer potent and durable treatments for areas of high unmet need.
Summary
Nvelop Therapeutics is a Biotech company based in Cambridge, United States, founded in 2022. It has raised $100.0M in total across 1 round, most recently a $100.0M Seed round in Apr 2024. Investors include Newpath Management, Atlas Venture and F-Prime Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nvelop-therapeutics"><img src="https://indexed.vc/api/badge/company/nvelop-therapeutics" alt="Nvelop Therapeutics on Indexed.vc" width="260" height="76" /></a>